Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
LZM005 is an ERBB2 (HER2)-targeted antibody with increased affinity for domain II, which may have antitumor activity (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 1042).
|DrugClasses||HER2 (ERBB2) Antibody 60|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Docetaxel + LZM005 + Trastuzumab||Docetaxel LZM005 Trastuzumab||0||0|